SYNLAB AG (“SYNLAB” or “the Group”, FSE: SYAB), the leader in medical diagnostic services and specialty testing in Europe, today announced its unaudited Q1 2024 results. The Group reports strong ...
EQS-News: SYNLAB AG / Key word(s): Quarterly / Interim Statement/Quarter Results SYNLAB AG: SYNLAB reports strong start to fiscal year 2023 10.05.2023 / 07:30 CET/CEST The issuer is solely responsible ...
SYNLAB reports a strong start to the fiscal year 2022 12.05.2022 / 07:00 The issuer is solely responsible for the content of this announcement. SYNLAB, the leader in medical diagnostic services and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback